GP73 also enhances p-Smad2 and p-Smad3 by TGF-β1, resulting in the promotion of Epithelial-Mesenchymal Transition and invasion of HCC cells [14]. The gene discussed is SMAD2; the disease is hepatocellular carcinoma.